Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060679
Filing Date
2023-11-08
Accepted
2023-11-08 07:22:35
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cgem-20230930.htm   iXBRL 10-Q 2345825
2 EX-10.1 cgem-ex10_1.htm EX-10.1 20829
3 EX-31.1 cgem-ex31_1.htm EX-31.1 15749
4 EX-31.2 cgem-ex31_2.htm EX-31.2 15529
5 EX-32.1 cgem-ex32_1.htm EX-32.1 15390
  Complete submission text file 0000950170-23-060679.txt   8338260

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cgem-20230930_lab.xml EX-101.LAB 466388
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cgem-20230930.xsd EX-101.SCH 68307
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cgem-20230930_pre.xml EX-101.PRE 339097
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cgem-20230930_cal.xml EX-101.CAL 45310
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cgem-20230930_def.xml EX-101.DEF 172596
61 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20230930_htm.xml XML 1483302
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Filer) CIK: 0001789972 (see all company filings)

EIN.: 813867811 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39856 | Film No.: 231385953
SIC: 2836 Biological Products, (No Diagnostic Substances)